WNT3 decreases the GCP proliferation marker <i>Atoh1</i> and increases the GCP differentiation marker PAX6. by Sandrine L. Anne (489755)

“…<p>(<i>A</i>) WNT3 decreased <i>Atoh1</i> mRNA levels after 6 h of treatment (Con=1; WNT3: <i>Atoh1</i>=0.52±0.06). …”

Glibenclamide Decreases ATP-Induced Intracellular Calcium Transient Elevation via Inhibiting Reactive Oxygen Species and Mitochondrial Activity in Macrophages by Duo-ling Li (523730)

“…The transient elevation was inhibited by an ROS scavenger (tiron) and mitochondria inhibitor (rotenone). Glibenclamide and 5-hydroxydecanoate (5-HD) also decreased ATP-induced [Ca²⁺]_i transient elevation, but pinacidil and other unselective K⁺ channel blockers had no effect. …”

Necdin deficiency decreases <i>p16</i> expression and increases <i>Cdk1</i> expression in primary NPCs. by Ryohei Minamide (505053)

Relationship between a simplified SCOPE score at start of treatment with anakinra and clinical outcome at 60 days. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

Percentage of patients with hypokalemia (potassium <3.5 mEq/L), hyperkalemia (potassium >5.5 mEq/L) and hyperphosphatemia (phosphate >5.5 mg/dL) before (black/gray columns) and aft... by Daniela Peruzzo (11570702)

Analysis of the ¹H-¹⁵N HSQC Spectra of mS100A4 in Complex with EGF. by Ching Chang Cho (3080076)

“…<p>(A) Overlaid ¹H-¹⁵N HSQC spectra of 0.5 mM ¹⁵N-labeled free mS100A4 (red) and mS100A4: EGF, molar ratio = 1:0.3 (green), 1:0.6 (blue), and 1:1 (white), with the intensity drop indicated by green boxes. …”

Analysis of the ¹H-¹⁵N HSQC Spectra of mS100A4 in Complex with Amlexanox. by Ching Chang Cho (3080076)

“…(C) Ribbon representation of mS100A4, with residues that exhibited a decrease in cross-peak intensity mapped (red) on the ribbon diagram.…”

Relationship between Differential Hepatic microRNA Expression and Decreased Hepatic Cytochrome P450 3A Activity in Cirrhosis by Raj Vuppalanchi (458660)

“…In this study, we examined if certain microRNAs (miRNA) are associated with decreased hepatic CYP3A activity in cirrhosis.…”

Over-expression of Ly-GDI decreases IgG immune complex-induced generation of pro-inflammatory mediators in BAL fluids. by Chunguang Yan (324677)

DualAG decreased TG synthesis in DIO mice. by Vijay R. More (4532392)

RFR magnitude as a function of time after stimulus level changes (“transient”) and steady state response magnitude to the same stimulus level. by Vladimir V. Popov (5563067)

“…The left column–records after level changes from 40-dB (A) to 10-dB (D) increase; the right panel–records from 40-dB (E) to 10-dB (H) decrease. …”

Decreased Na_v1.5 expression in <i>Scn5a</i>^+/− mice. by Anne-Laure Leoni (366926)

Decreased membrane localization of myrGFP in <i>ACBD6</i>-deficient cells. by Eric Soupene (64584)

Effects of Remote Ischemic Preconditioning on Decreasing Troponin Release in Patients Not Taking Sulfonylureas After Cardiac Surgery – A Meta-Analysis by Xiaotong Wang (276499)

Effects of Remote Ischemic Preconditioning on Decreasing Troponin Release in Patients Not Taking Sulfonylureas After Cardiac Surgery – A Meta-Analysis by Xiaotong Wang (276499)

Image2_A Novel Plant Leaf Patch Absorbed With IL-33 Antibody Decreases Venous Neointimal hyperplasia.TIFF by Boao Xie (11621803)

“…IL-33 plays a role in the neointimal formation after vascular injury. We hypothesized that plant leaves can absorb therapeutic drug solution and can be used as a patch with drug delivery capability, and plant leaves absorbed with IL-33 antibody can decrease venous neointimal hyperplasia in the rat IVC venoplasty model.…”

Image1_A Novel Plant Leaf Patch Absorbed With IL-33 Antibody Decreases Venous Neointimal hyperplasia.TIFF by Boao Xie (11621803)

“…IL-33 plays a role in the neointimal formation after vascular injury. We hypothesized that plant leaves can absorb therapeutic drug solution and can be used as a patch with drug delivery capability, and plant leaves absorbed with IL-33 antibody can decrease venous neointimal hyperplasia in the rat IVC venoplasty model.…”

Glucose-lowering efficacy. by Sungmin Kim (628527)

Subjects:

eGFR values and mean eGFR change after the use of dulaglutide. by Sungmin Kim (628527)

Subjects:

Baseline characteristics. by Sungmin Kim (628527)

Subjects: